|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158.40 EUR | -2.82% |
|
-1.86% | +33.11% |
| Jul. 24 | Healthcare Shares Benefit From Rotation Away From AI Darlings -- Health Care Roundup | DJ |
| Jul. 24 | Ipsen Provides Update On Phase III BOLD Trial In Biliary Atresia | CI |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 12,987 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 32.93% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 11,642 | 10,641 | 9,854 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 26.2% | -8.6% | -7.4% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 14.4x | 14.1x | 14x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.59x | 2.2x | 1.91x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | 5.72x | 20.47x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 3.01x | 2.87x | 2.74x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.7x | 2.35x | 2.08x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 6.95x | 6.33x | 5.91x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 8x | 7.24x | 6.71x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 9.87x | 8.94x | 8.14x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 10.1% | 11.2% | 12.3% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.518 | 1.502 | 1.611 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.96% | 0.95% | 1.02% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 10.99 | 11.26 | 11.34 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 13.8% | 13.3% | 14.2% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,311 | 4,527 | 4,743 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,675 | 1,681 | 1,667 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,456 | 1,470 | 1,469 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 939.6 | 953.7 | 955 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,345 | -2,347 | -3,134 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 158.40 | 158.40 | 158.40 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 2/11/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.41x | 2.7x | 6.95x | 0.96% | 14.79B | ||
| 35.7x | 12.68x | 26.75x | 0.57% | 1,067B | ||
| 28.24x | 6.45x | 17.87x | 2.04% | 635B | ||
| 33.87x | 7.65x | 15.73x | 2.65% | 458B | ||
| 19.22x | 4.69x | 11.57x | 2.82% | 347B | ||
| 21.56x | 5.71x | 14.24x | 2.81% | 295B | ||
| 21.1x | 4.45x | 12.31x | 1.98% | 262B | ||
| 14.14x | 5.26x | 10.84x | 3.54% | 216B | ||
| 24.66x | 6.48x | 11.43x | 2.68% | 203B | ||
| -46.58x | 5.59x | 30.88x | 2.55% | 161B | ||
| Average | 16.63x | 6.17x | 15.86x | 2.26% | 365.78B | |
| Weighted average by Cap. | 24.84x | 7.93x | 18.66x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
















